- Home
- GOCO vs CUE Comparison
GOCO vs CUE Comparison
Compare GOCO & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOCO | CUE |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 26.0M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GOCO | CUE |
|---|---|---|
| Price | $1.33 | $0.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $4.75 | $3.00 |
| AVG Volume (30 Days) | 103.9K | ★ 920.6K |
| Earning Date | 03-31-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.11 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $361,845,000.00 | $27,466,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $105.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 195.75 |
| 52 Week Low | $1.31 | $0.21 |
| 52 Week High | $11.88 | $1.03 |
Technical Indicators
Market Signals| Indicator | GOCO | CUE |
|---|---|---|
| Relative Strength Index (RSI) | 38.32 | 28.82 |
| Support Level | N/A | N/A |
| Resistance Level | $2.48 | $0.35 |
| Average True Range (ATR) | 0.21 | 0.02 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 2.88 | 0.50 |
Price Performance
Historical ComparisonAbout GOCO GoHealth Inc.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.